McKesson Resultados de beneficios anteriores
Pasado controles de criterios 2/6
McKesson ha aumentado sus beneficios a una tasa media anual de 36.4%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento anual de 7.1%. Los ingresos han ido creciendo a una tasa media de 6.8% al año.
Información clave
36.4%
Tasa de crecimiento de los beneficios
39.6%
Tasa de crecimiento del BPA
| Crecimiento de la industria Healthcare | 8.5% |
| Tasa de crecimiento de los ingresos | 6.8% |
| Rentabilidad financiera | n/a |
| Margen neto | 1.0% |
| Próxima actualización de resultados | 07 May 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?
Mar 14
McKesson: GLP-1 Contributed More Than 1/3 Of Growth
Feb 19McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues
Feb 16Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking
Jan 29McKesson: Why The Company Is Too Richly Valued
Jan 19If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity
Nov 20McKesson: GLP-1 Medications Tailwinds And Massive Share Repurchase
Nov 08Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?
Oct 30McKesson: Still Trading For A Huge Discount
Sep 06Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors
Aug 21Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?
Jul 27McKesson: Outlook Remains Positive, I Reiterate My Buy Recommendation
Jun 28Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors
May 23Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?
Apr 17Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?
Feb 22McKesson Corporation: Looking Forward To Long-Term Low-Teens EPS Growth
Feb 08McKesson Non-GAAP EPS of $6.90 beats by $0.54, revenue of $70.5B misses by $480M
Feb 01McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price
Jan 125 Reasons Why I Am Considering Adding McKesson To My Portfolio
Dec 27McKesson Corporation: Still Trading Below Intrinsic Value
Dec 13Duration: The Time Bomb In Your Portfolio - McKesson And PayPal In Focus
Oct 08McKesson extends distribution partnership with CVS Health
Sep 29An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 50% Undervalued
Sep 19McKesson to acquire Rx Savings Solutions in $875M deal
Sep 19Cardinal Health, McKesson hit 52-week highs; up 35% and 50% YTD
Aug 15McKesson raises fiscal 2023 adjusted diluted EPS following strong quarterly results
Aug 03McKesson raises dividend by 15% to $0.54/share
Jul 25McKesson Is Still An Attractive Dividend Growth Stock
Jul 10McKesson: Best Of Breed In Drug Distributor Oligopoly
Jun 20McKesson: Still Profitable Without COVID-19 Boosts
Jun 04Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero McKesson. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 23 | 301,506 | 2,998 | 8,432 | 0 |
| 30 Sep 23 | 291,098 | 3,487 | 7,829 | 0 |
| 30 Jun 23 | 284,040 | 3,755 | 7,687 | 0 |
| 31 Mar 23 | 276,711 | 3,563 | 7,776 | 0 |
| 31 Dec 22 | 273,903 | 3,146 | 8,343 | 0 |
| 30 Sep 22 | 272,027 | 2,061 | 9,545 | 0 |
| 30 Jun 22 | 268,446 | 1,396 | 10,264 | 0 |
| 31 Mar 22 | 263,966 | 1,119 | 10,537 | 0 |
| 31 Dec 21 | 257,006 | 1,415 | 10,230 | 0 |
| 30 Sep 21 | 250,991 | -4,804 | 9,416 | 0 |
| 30 Jun 21 | 245,223 | -4,494 | 8,977 | 0 |
| 31 Mar 21 | 238,228 | -4,538 | 8,849 | 0 |
| 31 Dec 20 | 237,621 | -4,189 | 9,028 | 0 |
| 30 Sep 20 | 234,194 | 2,228 | 9,150 | 0 |
| 30 Jun 20 | 231,002 | 922 | 9,139 | 0 |
| 31 Mar 20 | 231,051 | 906 | 9,182 | 0 |
| 31 Dec 19 | 224,945 | -905 | 9,641 | 71 |
| 30 Sep 19 | 221,981 | -626 | 9,160 | 71 |
| 30 Jun 19 | 217,440 | 601 | 8,642 | 71 |
| 31 Mar 19 | 214,319 | 33 | 8,437 | 0 |
| 31 Dec 18 | 213,518 | -319 | 8,362 | 125 |
| 30 Sep 18 | 210,927 | 113 | 8,197 | 125 |
| 30 Jun 18 | 209,913 | -384 | 8,300 | 125 |
| 31 Mar 18 | 208,357 | 62 | 8,138 | 125 |
| 31 Dec 17 | 205,442 | 4,805 | 7,464 | 341 |
| 30 Sep 17 | 201,955 | 4,539 | 7,503 | 341 |
| 30 Jun 17 | 199,851 | 4,846 | 7,317 | 341 |
| 31 Mar 17 | 198,533 | 5,194 | 7,447 | 341 |
| 31 Dec 16 | 196,498 | 2,051 | 7,149 | 392 |
| 30 Sep 16 | 194,267 | 2,044 | 7,264 | 392 |
| 30 Jun 16 | 193,071 | 2,359 | 7,283 | 392 |
| 31 Mar 16 | 190,884 | 2,290 | 7,379 | 392 |
| 31 Dec 15 | 189,131 | 2,237 | 7,573 | 392 |
| 30 Sep 15 | 187,716 | 2,090 | 7,342 | 392 |
| 30 Jun 15 | 183,115 | 1,950 | 7,781 | 392 |
| 31 Mar 15 | 179,045 | 1,775 | 7,901 | 392 |
| 31 Dec 14 | 171,952 | 1,780 | 7,323 | 457 |
| 30 Sep 14 | 159,804 | 1,462 | 6,932 | 457 |
| 30 Jun 14 | 148,629 | 1,402 | 6,143 | 457 |
| 31 Mar 14 | 137,392 | 1,419 | 5,388 | 457 |
| 31 Dec 13 | 130,076 | 1,278 | 4,675 | 433 |
| 30 Sep 13 | 126,839 | 1,420 | 4,554 | 433 |
| 30 Jun 13 | 123,609 | 1,396 | 4,298 | 433 |
Ingresos de calidad: MCK tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio(1%) de MCK son inferiores a los del año pasado (1.1%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: MCK ha pasado a ser rentable en los últimos 5 años, con un crecimiento de los beneficios de 36.4% al año.
Acelerando crecimiento: MCK ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: MCK tuvo un crecimiento negativo de los beneficios (-4.7%) durante el año pasado, lo que dificulta la comparación con la media de la industria Healthcare (7.3%).
Rentabilidad financiera
Alta ROE: El pasivo de MCK supera su activo, por lo que es difícil calcular su rentabilidad financiera.